FDA Approves Eton Pharma's KHINDIVI For Pediatric Adrenocortical Insufficiency
29/5 04:34
(RTTNews) - Eton Pharmaceuticals Inc. (ETON) announced that the U.S. Food and Drug Administration has approved a New Drug Application (NDA) for KHINDIVI (hydrocortisone) Oral Solution. The drug is intended as a replacement therapy for pediatric patients aged five years and older...